Pulmonary-artery denervation, in addition to guideline-directed medical therapy, resulted in fewer events of clinical worsening than medical therapy alone in patients with pulmonary hypertension ...
Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be inadvertently consumed or inhaled, is associated with a ...
In IDEAL-AF, simultaneously published in JAMA, adjunctive low-voltage zone ablation following pulmonary vein isolation improved rhythm outcomes and health-related quality of life without increasing ...
A three-month direct oral anticoagulant (DOAC) regimen shortly after successful TAVR substantially reduced hypoattenuated leaflet thickening (HALT) during treatment vs. single antiplatelet therapy ...
It is a tremendous honor to serve as Chair of ACC's Women in Cardiology (WIC) Member Section Leadership Council. I am deeply grateful to the visionary leaders who have built this extraordinary ...
Work, practice, expense and liability relative value units (RVUs) are updated annually through the Centers for Medicare and Medicaid Services' (CMS') Physician Fee Schedule (PFS) rulemaking. In ...
The Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Physician Fee Schedule (PFS) final rule, updating the PFS conversion factor from $32.3465 to $33.5675 for qualifying ...
Lowering LDL-C to <55 mg/dL in patients with atherosclerotic cardiovascular disease (ASCVD) reduced the rate of major cardiovascular events by one-third, according to the Ez-PAVE trial presented ...
Inflammation plays a central role in the pathogenesis of atherosclerosis and cardiovascular disease. 1 Atherosclerosis in particular is an inflammatory process that involves endothelial dysfunction, ...
About 50% of U.S. adults will develop high BP during their lifetime. High BP is the most prevalent and modifiable risk factor for cardiovascular disease and all-cause mortality. The overarching BP ...
The U.S. Food and Drug Administration (FDA) has approved Cardamyst™ (etripamil) nasal spray to treat adults with paroxysmal supraventricular tachycardia (PSVT). This rapid-acting, self-administered ...
Global death counts due to cardiovascular disease (CVD) increased from 12.4 million in 1990 to 19.8 million in 2022, reflecting global population growth and aging and the contributions from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results